DDX5 and colorectal cancer: Among them, FL118 has shown potent antitumor effects by reducing DDX5 expression in models of pancreatic and colorectal cancer, as well as chronic myeloid leukemia (Ling et al., 2022; Ling et al., 2024; Takeda et al., 2024).